Research summary, original research, 2016

Safety and efficacy of applying a low-dose radiation fluoroscopy protocol in device implantations

Attanasio P, Mirdamadi M, Wielandts JY, Pieske B, Blaschke F, Boldt LH, et al.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. 2016

Read the original paper

In plain language

In 584 pacemaker and defibrillator implantations at one hospital, a low-frame-rate, optimized-settings protocol was associated with 64% lower patient dose-area product without longer procedures or more complications. Staff dose was not measured, though lower patient dose usually means less scatter.

At a glance

Type of study
Original research, Retrospective cohort study
Who was studied
Patients
Size
n = 584 patients
Summary based on
the abstract

What it found

  • Introducing the dose reduction protocol was associated with a 64% reduction in dose-area product for CIED implantations.

    Key figures: 64% reduction; 1372 ± 2659 vs. 3792 ± 5025 cGcm2, P < 0.001

  • Fluoroscopy time and procedure time did not increase after the protocol was introduced.

    Key figures: fluoroscopy 13 ± 15 vs. 13 ± 15 min; procedure 93 ± 52 vs. 92 ± 52 min

  • Complication rates did not differ significantly between before and after groups.

  • The protocol used reduced frame rates plus optimized image processing and exposure settings.

    Key figures: 4 FPS fluoroscopy, 7.5 FPS cine

Limits to keep in mind

Single-centre retrospective before-after chart review measuring patient dose-area product only; staff dose was not measured. Abstract only, with limited detail on how complications were assessed.

How this summary was made

ORSIF prepared this summary with AI assistance from the abstract of the paper. A program then checked that the passage supporting each finding appears word for word in that source. A person has not yet reviewed each summary, so read the original before relying on a number. ORSIF summarizes research and does not endorse any product or company. Report a problem with this summary.

Prepared November 3, 2026.